Sunshine Biopharma
SBFM
7 hedge funds and large institutions have $308K invested in Sunshine Biopharma in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
17% more funds holding
Funds holding: 6 → 7 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
59% less capital invested
Capital invested by funds: $760K → $308K (-$452K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$43.4K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$21.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$304K |
| 2 |
VF
Virtu Financial
New York
|
-$52K |
| 3 |
DWM
Dakota Wealth Management
Palm Beach Gardens,
Florida
|
-$22K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
| 5 |
Morgan Stanley
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $221K | -$304K | -14 | -50% |
|
|
2
Two Sigma Investments
New York
| $29K | +$43.4K | +2 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $15K | – | – | – |
|
|
TSS
4
Two Sigma Securities
New York
| $13K | – | – | – |
|
|
5
Bank of America
Charlotte,
North Carolina
| $13K | +$21.7K | +1 | New |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $11K | +$21.7K | +1 | New |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $5K | – | – | – |
|
8
National Bank of Canada
Montreal,
Quebec, Canada
| $1K | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $61 | – | – | – |
|
10
Bank of Montreal
Toronto,
Ontario, Canada
| $33 | – | – | – |
|
|
VF
11
Virtu Financial
New York
| – | -$52K | -2 | Closed |
|
|
DWM
12
Dakota Wealth Management
Palm Beach Gardens,
Florida
| – | -$22K | -1 | Closed |
|
|
13
Morgan Stanley
New York
| – | -$7K | – | – |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$9K | – | – |
|
SBFM Hedge Fund Activity: Q3 2022 in Review
7 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q3 2022, worth a combined $308K — down 59% from $760K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SBFM positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $43.4K. The largest seller was Bridgeway Capital Management, cutting an estimated $304K.
- 7 institutional investors held Sunshine Biopharma (SBFM) as of Q3 2022, up from 6 in Q2 2022.
- Funds reported $308K of Sunshine Biopharma stock for Q3 2022, down 59% quarter-over-quarter.
- 3 funds opened new Sunshine Biopharma positions in Q3 2022 and 2 closed out, a net change of +1 holder.
- The largest Sunshine Biopharma buyer in Q3 2022 was Two Sigma Investments, an estimated $43.4K added.
- The largest Sunshine Biopharma seller in Q3 2022 was Bridgeway Capital Management, an estimated $304K sold.
Based on aggregated 13F filings for Q3 2022.